SMA
EUCRU

Sage Mountain Advisors’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Sage Mountain Advisors’s Portfolio EUCRU Stock Details EUCRU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-86,890
Closed -$860K – 552
2022
Q2 		$860K Sell
86,890
-7,750
-8% -$77K 0.15% 115
2022
Q1 		$933K Sell
94,640
-2,000
-2% -$19.8K 0.15% 122
2021
Q4 		$964K Sell
96,640
-1,980
-2% -$19.9K 0.12% 147
2021
Q3 		$977K Buy
98,620
+2,650
+3% +$26.5K 0.14% 130
2021
Q2 		$979K Hold
95,970
– – 0.16% 116
2021
Q1 		$965K Hold
95,970
– – 0.21% 82
2020
Q4 		$1.02M Buy
+95,970
New +$975K 0.34% 46

Other funds holding EUCRU

Verition Fund Management
Verition Fund Management Greenwich, Connecticut $10.3B AUM 30.69% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $421M AUM 9.46% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $6.41B AUM 4.78% 1-Year Est. Return